In a long-awaited milestone in the gene therapy space, the Food and Drug Administration (FDA) approved two gene therapies toContinue Reading Gene Therapy Approvals Gain Steam in 2023: FDA Approves First Gene Therapies for Sickle Cell Disease
Gene therapy is part of a new wave of medicine that approaches disease treatment by addressing the root causes rather…Continue Reading Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
After decades of intense scientific research into developing gene editing technologies, and more than a few setbacks, the field has…Continue Reading Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare Diseases
The alternative (“alt-“) animal products industry is growing increasingly more popular each year, causing an increased demand in foods made…Continue Reading Foodtech Patents: Who’s on the Board and What Moves are they Making?
Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and…Continue Reading The Evolving Gene Editing Landscape: From Research Tool to Market
The food tech industry has been rapidly growing in recent years with the rise in popularity of alternative (“alt-“)…
Continue Reading Foodtech Pioneer Impossible Foods Sues Competitor Motif for Patent Infringement
In April of 2021, we provided a three-part series relating to the IP and Competitive Landscape for the mRNA market.
Continue Reading mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook